JP2009520480A5 - - Google Patents

Download PDF

Info

Publication number
JP2009520480A5
JP2009520480A5 JP2008546287A JP2008546287A JP2009520480A5 JP 2009520480 A5 JP2009520480 A5 JP 2009520480A5 JP 2008546287 A JP2008546287 A JP 2008546287A JP 2008546287 A JP2008546287 A JP 2008546287A JP 2009520480 A5 JP2009520480 A5 JP 2009520480A5
Authority
JP
Japan
Prior art keywords
polypeptide
dimer
polypeptide dimer
monomer
fragments
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2008546287A
Other languages
English (en)
Japanese (ja)
Other versions
JP5390191B2 (ja
JP2009520480A (ja
Filing date
Publication date
Priority claimed from EP05028420A external-priority patent/EP1801121A1/en
Application filed filed Critical
Publication of JP2009520480A publication Critical patent/JP2009520480A/ja
Publication of JP2009520480A5 publication Critical patent/JP2009520480A5/ja
Application granted granted Critical
Publication of JP5390191B2 publication Critical patent/JP5390191B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2008546287A 2005-12-23 2006-12-22 医薬として有用な可溶性gp130分子変異体 Active JP5390191B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP05028420A EP1801121A1 (en) 2005-12-23 2005-12-23 Soluble gp130 molecule variants useful as a medicament
EP05028420.7 2005-12-23
PCT/EP2006/012515 WO2007071449A1 (en) 2005-12-23 2006-12-22 Soluble gp130 molecule variants useful as a medicament

Publications (3)

Publication Number Publication Date
JP2009520480A JP2009520480A (ja) 2009-05-28
JP2009520480A5 true JP2009520480A5 (https=) 2010-01-21
JP5390191B2 JP5390191B2 (ja) 2014-01-15

Family

ID=36233865

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008546287A Active JP5390191B2 (ja) 2005-12-23 2006-12-22 医薬として有用な可溶性gp130分子変異体

Country Status (9)

Country Link
US (1) US7851182B2 (https=)
EP (2) EP1801121A1 (https=)
JP (1) JP5390191B2 (https=)
AT (1) ATE471945T1 (https=)
AU (1) AU2006328909A1 (https=)
CA (1) CA2633213A1 (https=)
DE (1) DE602006015103D1 (https=)
ES (1) ES2347694T3 (https=)
WO (1) WO2007071449A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1873166T3 (da) 2006-06-30 2010-12-20 Conaris Res Inst Ag Forbedrede sgp 130Fc-dimerer
EP2174667B1 (en) * 2007-07-26 2017-01-04 Osaka University Agent for treatment of ophthalmia containing interleukin-6 receptor inhibitor as active ingredient
EP2050759A1 (en) * 2007-10-19 2009-04-22 CONARIS research institute AG Soluble gp 130 muteins with improved binding activity
RS65665B1 (sr) 2014-12-01 2024-07-31 Ferring Bv Selektivne kompozicije inhibitora il-6-trans-signalizacije
LT3226888T (lt) 2014-12-01 2021-05-25 Ferring B.V. Selektyvaus il-6-trans-signalinio inhibitoriaus skyrimas
US20190002915A1 (en) * 2015-12-14 2019-01-03 The Trustees Of The University Of Pennsylvania Compositions and methods for regulatable antibody expression

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994012520A1 (en) * 1992-11-20 1994-06-09 Enzon, Inc. Linker for linked fusion polypeptides
CA2344277A1 (en) * 1998-09-22 2000-03-30 University Of Maryland, Baltimore Cystine knot growth factor mutants
CZ20012406A3 (cs) * 1999-01-07 2002-03-13 Lexigen Pharmaceuticals, Corp. Exprese a export proteinů působících proti obezitě jako Fc fúzních proteinů
EP1148065B1 (en) * 2000-04-21 2008-01-02 CONARIS research institute AG Fusion proteins comprising two soluble gp130 molecules
ES2302845T3 (es) * 2001-10-19 2008-08-01 Zymogenetics, Inc. Factor de crecimiento dimerizado y materiales y metodos para producirlo.
EP1491554A1 (en) * 2003-06-23 2004-12-29 CONARIS research institute AG PEGylated soluble gp130-dimers useful as a medicament
JP2008504012A (ja) * 2004-01-28 2008-02-14 シントニックス・ファーマシューティカルズ・インコーポレーテッド 不妊治療のためのへテロ二量体卵胞刺激ホルモン−Fc(FSH−Fc)融合タンパク質

Similar Documents

Publication Publication Date Title
JP2023058590A5 (https=)
US20130164286A1 (en) Fc FUSION PROTEINS
JP2010519293A5 (https=)
JP2004503213A5 (https=)
JP2014503198A5 (https=)
JP2017529059A5 (https=)
JP2020500015A5 (https=)
JP2013513377A5 (https=)
WO2008000516B1 (en) IMPROVED sgp130Fc DIMERS
JP2003530070A5 (https=)
JP2012522529A5 (https=)
JP2015508077A5 (https=)
JP2015504675A5 (https=)
JP2010529860A5 (https=)
JP2008507298A5 (https=)
JP2005523681A5 (https=)
CN102898526A (zh) 一种肿瘤坏死因子相关凋亡诱导配体融合蛋白及其制备和应用
CN114133435B (zh) 一种类弹性蛋白多肽及应用
JP2018537089A5 (https=)
JP2020517260A5 (https=)
JP2008509682A5 (https=)
JP2009520480A5 (https=)
JP2014517690A5 (https=)
JP2009509553A5 (https=)
IL209595A (en) Isolated nucleic acid, expression vector and host cell containing it, isolated polypeptide encoded by it and chimeric polypeptide containing it, process for preparation, oligopeptide hhipl l2 mimics loop, preparations containing it and methods for its production